High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

NCT03870529 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Slow accruals

Conditions

Non Small Cell Lung Cancer
Stage I Lung Cancer
Stage Ib Lung Carcinoma
Stage IA Lung Carcinoma AJCC V7
Stage IIA Lung Carcinoma
Stage IIIA Lung Carcinoma

Interventions

DRUG: Vitamin A Compound
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]